19 May 2017 (Friday)
| Time | Programme | |
| 09:00 – 09:30 | Registration | |
| 09:30 – 11:00 | Plenary Lecture 1: Basic Sciences Chairpersons: X.Y. GUAN (Hong Kong), Tak-wah MAK (Canada) Beyond Oncogenes: Emerging Strategies in Anti-cancer Targets Tak-wah MAK (Canada) Whole-exome Sequencing-identified Macrophage-stimulating Receptor 1 (MST1R) in NPC Genetic Susceptibility Maria LUNG (Hong Kong) Hepatocellular Carcinoma Treatment at the Intersection between Antiangiogenic Therapy and Immunotherapy Dan G. DUDA (USA) Salon 5-6 |
|
| 11:00 – 11:30 | Coffee Tea Break & Exhibition | |
| 11:30 – 12:45 | Concurrent Session 1: Sarcoma Chairpersons: Ying-lee LAM (Hong Kong), Tony Wai-hung SHEK (Hong Kong) Excision of Soft Tissue Sarcoma: Preopeartive Planning Ying-lee LAM (Hong Kong) Advances of Radiation Oncology in the Management of Soft Tissue Sarcoma  Brian O’SULLIVAN (Canada) An Update and Concise Guide to Sarcomas Robin JONES (UK) Salon 5-6 |
Concurrent Session 2: Drug Development in Oncology Chairperson: Lilian SIU (Canada) Early Phase Clinical Trials in the Era of Immunotherapy Lilian SIU (Canada) The Challenges and Opportunities of Early Clinical Trials in Hong Kong Joanne CHIU (Hong Kong) Early Phase Clinical Trials in the Era of Genomic Medicine Timothy YAP (USA) Salon 1-4 |
| 12:45 – 14:15 | Lunch Symposium (Sponsored by Amgen) Chairperson: Chi-leung CHIANG (Hong Kong) Optimizing Treatment Outcomes in Metastatic Colorectal Cancer Niall TEBBUTT (Australia) Anti-EGFR Therapy: the Right Patient at the Right Time Ka-on LAM (Hong Kong) Salon 5-6 |
Lunch Symposium (Sponsored by BMS) Chairpersons: Thomas YAU (Hong Kong), Roger NGAN (Hong Kong) Emerging Treatment in Recurrent/Metastatic Head and Neck Cancers: A Changing Landscape with Potential to Impact on Primary Treatment of Locally Advanced Disease Kevin HARRINGTON (UK) Management of Advanced Hepatocellular Carcinoma: At the Dawn of a New Era Thomas YAU (Hong Kong) Salon 1-4 |
| 14:15 – 15:30 | Concurrent Session 3: Hepatocellular Cancer Chairpersons: Tan-to CHEUNG (Hong Kong), Masatoshi KUDO (Japan) Role of SBRT for the Management of HCC Laura DAWSON (Canada) The Role of Radioembolization in the Management of HCC Pierce Kah-hoe CHOW (Singapore) Latest Advances in Using Molecular Targeted Therapy in Advanced HCC Patients Masatoshi KUDO (Japan) Salon 5-6 |
Concurrent Session 4: Neuroendocrine Tumour Chairpersons: Foon-yiu CHEUNG (Hong Kong), Roland LEUNG (Hong Kong) Update on Pathology of Neuroendocrine Tumors (NET) of the GI Tract Tony Wai-hung SHEK (Hong Kong) Progress in the Land of Small Tumours: Recent Advances and Future Directions in Advanced Neuroendocrine Tumours James YAO (USA) Use of Peptide Receptor Radionuclide Therapy (PPRT) for Treatment of Neuroendocrine Tumour Thomas Kam-chau CHENG (Hong Kong) Salon 1-4 |
| 15:30 – 16:00 | Coffee Tea Break & Exhibition | |
| 16:00 – 16:30 | Opening Ceremony Salon 5-6 |
|
| 16:30 – 18:30 | Plenary Lecture 2: Precision Medicine Chairpersons: Victor LEE (Hong Kong), Irene NG (Hong Kong) Personalized Medicine in Novel Clinical Candidates in Metabolic Pathways Tak-wah MAK (Canada) Advanced Melanoma in 2017: Immunotherapy vs. Targeted Therapy Victoria ATKINSON (Australia) Pan Histology Development of Targeted Therapies and Impact on Oncology Practice Steven Potts (USA) Management of Advanced Lung Cancer in the Era of Precision Medicine Corey J. LANGER (USA) Salon 5-6 |
|
| 18:30 - 19:45 | Satellite Symposium (Sponsored by Roche) Chairperson: James HO (Hong Kong), Victor LEE (Hong Kong) Updates on Cancer Immunotherapy (CIT) in Advanced NSCLC Kenneth O’BYRNE (Australia) PD-L1 Inhibition in Advanced NSCLC in Real-world Setting Ross SOO (Singapore) Salon 5-6 |
|
| 19:45 - | Gala Dinner (Sponsored by Roche) Salon 1-4 |
|
20 May 2017 (Saturday)
| Time | Programme | |
| 08:00 – 08:30 | Registration | |
| 08:30 – 10:30 | Plenary Lecture 3: Renaissance of Immuno-Oncology in Cancer Treatment (Sponsored by MSD) Chairpersons: Han-chong TOH (Singapore), Thomas YAU (Hong Kong) Tumour Heterogeneity and Immune Surveillance Charles SWANTON (UK) Immune Checkpoint Inhibitors in NSCLC: Now and Future Corey J. LANGER (USA) Role of Biomarker in NSCLC in the Era of Immuno-Oncology Rina HUI (Australia) The Role of Immunotherapy in Gastrointestinal Cancer Dung Thi LE (USA) Salon 5-6 |
|
| 10:30 – 10:50 | Coffee Tea Break & Exhibition (Sponsored by AstraZeneca) | |
| 10:50 – 12:05 | Concurrent Session 5: Clinical Oncology Chairpersons: Amy CHANG (Hong Kong), Dora KWONG (Hong Kong) Treatment of Nonsmall Cell Lung Cancer Patients with Uncommon Driver Mutations James Chih-hsin YANG (Taiwan) Recent Advances of SBRT for Hepatocellular Carcinoma Jinsil SEONG (South Korea) Combinatorial Immune Therapies to Enhance Outcomes in Solid Cancers Kevin HARRINGTON (UK) Salon 5-6 |
Concurrent Session 6: Haematology Chairperson: Yok-lam KWONG (Hong Kong) Novel Treatment Strategies in ALL: The Evolving Role of Immunotherapy David RITCHIE (Australia) (Sponsored by Amgen) Checkpoint Inhibition Where Do We Go from Here Yok-lam KWONG (Hong Kong) Immunotherapy: Changing the Landscape from Hodgkin to NK/T-cell Lymphoma Daryl TAN (Singapore) (Sponsored by MSD) Salon 1-4 |
| 12:05 – 13:30 | Lunch Symposium: A New Era in Cancer Management (Sponsored by MSD) Chairperson: Thomas YAU (Hong Kong) Advancement in Immunotherapy for Head & Neck Cancer Lillian SIU (Canada) Immune Checkpoint Inhibitors: New Treatment in Bladder Cancer Ravindran KANESVARAN (Singapore) Breakthrough Therapy in MSI-H Colorectal and Other Cancers Dung Thi LE (USA) Salon 5-6 |
|
| 13:30 – 14:40 | Concurrent Session 7: GI Oncology Chairpersons: Ka-on LAM (Hong Kong), Yim-kwan LAM (Hong Kong) Does Harnessing the Immune System Against Colorectal Cancer Work Han-chong TOH (Singapore) Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer Victor LEE (Hong Kong) What Have We Learned from Recent Major Clinical Trials for the Management of GEP-NET? Christos TOUMPANAKIS (UK) (Sponsored by Ipsen) Salon 5-6 |
Concurrent Session 8: Gynae Oncology Chairpersons: Karen CHAN (Hong Kong), Bradley J. MONK (USA) Targeted Therapy in Cervical Cancer Bradley J. MONK (USA) Primary Debulking Surgery (PDS) vs Interval Debulking Surgery (IDS): This is the Question for More Than 20 Years in the Surgical Management of Advanced Ovarian Cancer Sang-Yoon PARK (South Korea) Molecular Profiling of Ovarian Cancers to Optimize Therapy David TAN (Singapore) Salon 1-4 |
| 14:40 – 15:00 | Coffee Tea Break & Exhibition (Sponsored by Eli Lilly) | |
| 15:00 – 17:00 | Plenary Lecture 4: Advances in Global Oncology Practice Chairpersons: Joanne CHIU (Hong Kong), Gilberto de Lima LOPES, Jr (USA) What is Global Oncology? Gilberto de Lima LOPES, Jr (USA) Essential Pillars to Advance Oncology Practice Brian O’SULLIVAN (Canada) Renal Cell Cancer: Present and Future Bernard ESCUDIER (France) The Development of CDK 4/6 Inhibitors: From Bench to Clinic Richard FINN (USA) Salon 5-6 |
|
| 17:00 | Closing Ceremony Salon 5-6 |
|
The programme is subject to change without prior notice.
